Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot, Prospective, Multicenter, Open and Non-randomised Study: Definition of an Index of Anti Xa Value at the End of Hemodialysis Treatment.

NCT00781690 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT00781690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00781690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot, Prospective, Multicenter, Open and Non-randomised Study: Definition of an Index of Anti Xa Value at the End of Hemodialysis Treatment.
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2008
Completion date
February 28, 2010
Enrollment
53 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure